NASDAQ$BRKR

Bruker Corp · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Bruker's Q1 2024 financial results were announced, showcasing revenue growth and updated financial guidance.

Bruker reported a 5.3% year-over-year increase in revenue for Q1 2024, reaching $721.7 million. Organic revenue grew by 1.6%. The company updated its FY 2024 guidance, projecting revenue between $3.29 and $3.35 billion and non-GAAP EPS of $2.79 to $2.84.

  • Q1 2024 revenues reached $721.7 million, a 5.3% increase year-over-year.
  • GAAP EPS for Q1 2024 was $0.35, while non-GAAP EPS was $0.53.
  • FY 2024 revenue guidance was updated to $3.29 to $3.35 billion, reflecting 11% to 13% year-over-year growth.
  • Organic revenue growth for FY 2024 is maintained at 5% to 7%.

Headline financials

Total Revenue

$722M

Previous: $685M+5.3%
EPS

$0.35

Previous: $0.64-45.3%
Organic Revenue Growth

1.6%

Previous: 17.6%-90.9%
Non-GAAP Operating Margin

14.0%

Previous: 20.3%-31.0%
GAAP Operating Margin

9.0%

No prior period
Capital Expenditures

-$21.4M

Previous: -$25M+14.4%
Free Cash Flow

$29.5M

Previous: $51.5M-42.7%
Net Income

$50.9M

Previous: $76.5M-33.5%
Operating Income

$64.8M

Previous: $123M-47.2%
Gross Profit

$353M

Previous: $360M-1.9%
Cash & Equivalents

$340M

Previous: $598M-43.1%
Total Assets

$4.51B

Previous: $3.76B+19.7%
R&D Expense

$81.7M

No prior period
Stock-Based Comp

$5.3M

Previous: $6.5M-18.5%

Revenue & EPS history

Bruker · Revenue · Quarterly

$722M

Q1 2024+5.3%vs Q1 2023
Beat estimate in 13 of 15 quarters(87%)
ActualEstimate

Revenue by segment

Bruker · $70.6M total across 1 segment · Q3 2023

  • BEST
    $70.6M+19.1%

Forward guidance

Bruker updated its FY 2024 guidance, now including the expected benefits of the Chemspeed and ELITech acquisitions. The updated FY 2024 guidance does not include the pending NanoString acquisition. Bruker now expects FY 2024 revenues of $3.29 to $3.35 billion and non-GAAP EPS of $2.79 to $2.84.

Tailwinds

  • Revenue is expected to be between $3.29 and $3.35 billion, up $60 million from prior guidance.
  • Reported revenue growth is projected to be 11% to 13% year-over-year.
  • Organic revenue growth is maintained at 5% to 7%.
  • CER revenue growth is expected to be 12% to 14%, including contributions from Chemspeed and ELITech acquisitions.
  • Non-GAAP EPS is projected to be $2.79 to $2.84, up $0.08 from prior guidance.

Headwinds

  • Foreign currency translation is expected to have a -1% headwind.
  • The pending NanoString acquisition is not included in the updated FY 2024 guidance.
  • Operating income decreased from $122.7 million in Q1 2023 to $64.8 million in Q1 2024.
  • Net income attributable to Bruker Corporation decreased from $76.5 million in Q1 2023 to $50.9 million in Q1 2024.
  • Non-GAAP operating income decreased from $139.4 million in Q1 2023 to $100.7 million in Q1 2024.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+0.8%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+3.3%

Avg return

30 days after

54%

35 / 65 earnings

Positive

+14.1%

Q1 2019

Best reaction

-13.1%

Q2 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+11.2%+13.8%+48.3%
Q4 2025-11.6%-10.2%-20.5%
Q3 2025+6.4%+2.5%+22.9%
Q1 2025+3.4%+2.1%-2.9%
Q4 2024-1.0%-1.7%-11.0%
Q3 2024-0.6%-2.7%-1.5%
Q2 2024-5.1%-2.4%+2.8%
Q1 2024-11.4%-5.9%-17.1%
Q4 2023+13.4%+15.9%+30.1%
Q3 2023+3.2%+2.2%+15.9%
Q2 2023-6.7%-7.6%-7.1%
Q1 2023-2.1%-4.9%-11.0%
Q4 2022+5.2%+7.3%+1.0%
Q3 2022+9.5%+8.7%+9.6%
Q2 2022-7.4%-9.3%-18.2%
Q1 2022+1.2%-4.0%+5.3%
Q4 2021-7.7%-3.9%-12.1%
Q3 2021+1.7%+1.7%+0.9%
Q2 2021-1.8%+0.4%+8.7%
Q1 2021-0.5%-0.0%+1.4%
Q4 2020+1.1%+3.5%-1.1%
Q3 2020+3.4%+9.2%+21.6%
Q2 2020+0.2%-1.1%-4.1%
Q1 2020+6.2%+4.3%+16.9%
Q4 2019-4.0%-21.4%-8.1%
Q3 2019+12.4%+6.8%+14.9%
Q2 2019-13.1%-12.7%-9.8%
Q1 2019+14.1%+11.3%+9.6%
Q4 2018+6.3%+7.4%+8.5%
Q3 2018+6.6%+6.9%+5.8%
Q2 2018+7.4%+7.0%+9.1%
Q1 2018+2.0%+2.9%+3.4%
Q4 2017-7.8%-5.9%-6.8%
Q3 2017+4.5%+2.8%+9.2%
Q2 2017-1.2%-3.1%+3.2%
Q1 2017+3.8%+4.7%+12.1%
Q4 2016-1.8%-1.2%-3.1%
Q3 2016+3.6%+8.9%+10.1%
Q2 2016-12.2%-10.6%-9.6%
Q1 2016-3.1%
Q4 2015+9.5%
Q3 2015+7.8%
Q2 2015-5.4%
Q1 2015+10.6%
Q4 2014-2.1%
Q3 2014-12.5%
Q2 2014-9.4%
Q1 2014-0.8%
Q4 2013+2.0%
Q3 2013-7.1%
Q2 2013+11.1%
Q1 2013-4.3%
Q4 2012+8.3%
Q3 2012+4.1%
Q2 2012-1.6%
Q1 2012+7.4%
Q4 2011-0.9%
Q4 2009-0.9%
Q3 2010-4.0%
Q3 2011-4.0%
Q2 2010+4.0%
Q2 2011+4.0%
Q1 2010+1.9%
Q4 2010+1.9%
Q1 2011+1.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro